Remarkably, our study clearly showed that an inappropriate level of PD-1 and CTLA-4 checkpoint expression in CD4 T cells in MM patients may also be responsible for the failure of ICIs, and in a proportion of NDMM patients, therapy with ICIs might even be deleterious by shortening the TTP. This evidence concerns the gene CD4 and Miyoshi myopathy.